Pro Medicus dividend and valuation
Valuation
Pro Medicus paid $0.69 per share in dividends over the last 12 months (yield 0.4%). Last ex-dividend date: September 7, 2026. The P/E ratio is 76.0. The average price target of 15 analysts is $203.21.
What would Pro Medicus's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 22, 2026
Pro Medicus compared with similar companies
Pro Medicus's Forward P/E: 79.9, +208% against the median of a group of 5 similar companies (26.0).
| Metric | Pro Medicus | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Forward P/E | 79.9 | 26.0 | 23.5 – 79.9 | Middle |
| Price/book | 43.5 | 5.80 | 4.13 – 13.9 | High |
| Price/sales | 75.0 | 12.5 | 7.14 – 54.8 | High |
| Gross margin | 99.8% | 75.0% | 58.0% – 90.3% | High |
| Operating margin | 74.9% | 19.5% | -71.5% – 28.5% | High |
| Net margin | 101.4% | 12.8% | -6.3% – 25.2% | High |
| ROE | 75.0% | 11.8% | -19.8% – 14.1% | High |
| Debt/equity | 0.00 | 0.08 | 0.02 – 0.70 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Pro Medicus: valuation over time
On the latest fiscal year's earnings (2026), Pro Medicus's P/E today is 74.0, below the median of its last 10 fiscal years (116.5; between 59.1 and 258.9 from 2017 to 2026). Relative to earnings, the stock costs less than it used to. The dividend yield (0.4%) is in line with the median of the last 10 fiscal years (0.4%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| Jun 2026 | $203.43 | $2.54 | 80.2 | $0.69 | 0.3% |
| Jun 2025 | $285.08 | $1.10 | 258.9 | $0.55 | 0.2% |
| Jun 2024 | $143.26 | $0.79 | 181.1 | $0.40 | 0.3% |
| Jun 2023 | $65.64 | $0.58 | 113.2 | $0.30 | 0.5% |
| Jun 2022 | $42.25 | $0.42 | 99.4 | $0.22 | 0.5% |
| Jun 2021 | $58.72 | $0.30 | 199.1 | $0.15 | 0.3% |
| Jun 2020 | $26.46 | $0.22 | 119.7 | $0.12 | 0.5% |
| Jun 2019 | $25.29 | $0.18 | 138.2 | $0.08 | 0.3% |
| Jun 2018 | $8.02 | $0.10 | 84.4 | $0.06 | 0.7% |
| Jun 2017 | $5.32 | $0.09 | 59.1 | $0.04 | 0.8% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $19.62B
- Enterprise value
- $19.37B
- P/E (trailing 12 months)
- 76.0
- PEG
- 2.67
- EV/EBITDA
- 98.6
- EV/revenue
- 74.0
Profitability and growth
- ROA
- 25.8%
- ROIC
- 34.4%
- Revenue growth (year over year)
- 18.2%
- Earnings growth (year over year)
- 48.4%
Financial health
- Total cash
- $252.28M
- Total debt
- $2.23M
- Current ratio
- 6.85
- Quick ratio
- 6.75
Dividends
- Annual dividend per share
- $0.69
- Dividend yield
- 0.4%
- Payout ratio
- 27.9%
- Ex-dividend date
- September 7, 2026
Analysts and estimates
- Average price target
- $203.21
- Median price target
- $222.00
- High price target
- $250.00
- Low price target
- $60.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- $2.35
- EPS estimate, current year
- $1.88
Shares and trading
- Beta
- 0.63
- Average volume
- 202.41K
- Shares outstanding
- 104.47M
- Float
- 53.32M
- Institutional ownership
- 25.9%
- Insider ownership
- 49.0%
